Mr. Pospisil’s primary focus is to assist biotechnology and biopharmaceutical companies in recruiting for positions such as chief executive officer, chief business officer, head of research and development and other key executives.

With over fifteen years in the industry as a successful executive and investor, Mr. Pospisil brings a thoughtful perspective to executive search, shaped by a breadth of experiences in new product development, business development, M&A, financings, strategy, company building, operational leadership and board functions from start-up, growth to mature biotechnology and biopharmaceutical companies.

Prior to joining Korn/Ferry, Mr. Pospisil was a co-founder and managing partner of both Aduro Capital LLC, an investment management company focused on the public healthcare sector and Aduro Partners LLC, an advisory firm focused on helping venture-backed and public life science companies assess, evaluate, partner opportunities and build businesses.

Previously, he was a partner in life science investments at Atlas Venture and earlier was with Millennium Pharmaceuticals, where his last position was director, strategy leadership. Earlier, he was a new product manager at Altus Biologics, a spin-out of Vertex Pharmaceuticals.

Mr. Pospisil holds a doctor of philosophy in organic chemistry from Harvard University and a bachelor’s degree in biochemistry from New York University. He also attended Harvard Business School’s Program for Management Development (PMD).